Protocol E

Type:
Prevalence / cross-sectional
Study Status:
Completed
Enrollment Status:
Closed
Countries:
Kenya;Rwanda
Partners:
Kenya AIDS Vaccine Initiative-Kangemi (KAVI-Kangemi), Nairobi, Kenya; Projet San Francisco (PSF-Kigali)-Kigali, Rwanda.

Study Summary:
To characterise immune responses to HIV vaccine encoded proteins in HIV infected individuals and assess cryopreservation of Peripheral Blood Mononuclear cells in preparation for preventive vaccine studies